NCT03530826

Brief Summary

All4Cure aims to accelerate learning about cancer by sharing medical information and research results from cancer patients with fellow cancer patients, oncologists, and scientists on the All4Cure website with the hope that together patients, clinicians and researchers can cure cancer faster.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
21mo left

Started Apr 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Apr 2018Jan 2028

Study Start

First participant enrolled

April 26, 2018

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

May 7, 2018

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 21, 2018

Completed
9.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2028

Last Updated

July 30, 2024

Status Verified

July 1, 2024

Enrollment Period

9.8 years

First QC Date

May 7, 2018

Last Update Submit

July 29, 2024

Conditions

Cancer

Outcome Measures

Primary Outcomes (1)

  • Change in tumor tissue molecular profiles

    Profiles of pre- and post-treatment tumor tissue will be compared.

    6 years

Interventions

No interventionOTHER

No Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult cancer patients

You may qualify if:

  • Have been diagnosed with cancer.
  • Be under the care of a physician.
  • Be 18 years of age or older.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

All4Cure

Seattle, Washington, 98136, United States

RECRUITING

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Carl A Blau, MD

    All4Cure

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Carl A Blau, MD

CONTACT

2064121787tony@all4cure.com

Kimberly A Burton, PhD

CONTACT

2069482711kaburton@all4cure.com

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
INDUSTRY
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 7, 2018

First Posted

May 21, 2018

Study Start

April 26, 2018

Primary Completion (Estimated)

January 31, 2028

Study Completion (Estimated)

January 31, 2028

Last Updated

July 30, 2024

Record last verified: 2024-07

Locations

US(1)